Argenx stock holds near its yearly high as targets rise

Published on 09/22/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Argenx stock closed at EUR 868.00 on September 21, 2026, up 1.6 percent. Its Nasdaq range spans USD 661.85 to USD 1,072.75.

Fotorealistisches Laborpanorama: Wissenschaftler in weißen Kitteln begutachten leuchtende Antikörper-3D-Modelle auf Bildschirmen, Stahltische mit Laborgeräten im Hintergrund — Argenx NL0010832176 Forscher analysieren im modernen Biopharma-Labor leuchtende Antikörper-Strukturen auf großen Monitoren, Illustration mit AI erstellt.

Argenx stock closed at EUR 868.00 in Frankfurt on September 21, 2026, gaining 1.6 percent, while the company continued to trade close to its established yearly range. The primary US listing remains the Nasdaq quotation, where the latest available snapshot showed USD 989.92, down 0.04 percent at 3:57 p.m. Eastern on September 22, 2026.

Nasdaq range remains wide

The Nasdaq quote had traded between USD 986.56 and USD 1,001.95 during the session on September 22, 2026. Its 52-week range extended from USD 661.85 to USD 1,072.75, placing the quoted price about 7.7 percent below the high and about 49.6 percent above the low.

Trading volume stood at 203,414 shares in the same snapshot. The comparison between the yearly high and low shows why daily movements remain less informative than the broader valuation range: the spread was USD 410.90, more than six times the reported one-day change of USD 0.40.

Consensus target stays above price

MarketBeat reported on September 22, 2026, that the consensus price target stood at USD 1,158.61, compared with the quoted USD 989.92. That difference represented about 17.0 percent, while the source described the overall consensus as Moderate Buy.

The same September 22, 2026 snapshot listed a high target of USD 1,415.00 and a low target of USD 910.00. The USD 505.00 gap between those estimates is wider than the USD 168.69 difference between the consensus target and the quoted share price, indicating a broad range of analyst assumptions.

Market value reaches EUR 53.58 billion

Argenx had a market capitalization of EUR 53.58 billion in September 2026, according to a market-capitalization snapshot dated September 22, 2026. That figure places the company among the largest listed biotechnology businesses by equity value, while the Frankfurt reference of EUR 868.00 on September 21, 2026 provides the clearest completed-session price for the European quotation.

For investors, the central measurable signal is the combination of a broad USD 661.85 to USD 1,072.75 Nasdaq range and a USD 1,158.61 consensus target. The valuation case therefore depends on continued operating delivery rather than on the 0.04 percent intraday move alone.

Argenx stock closes at EUR 868.00

Argenx stock closed at EUR 868.00 on the Frankfurt exchange on September 21, 2026, up 1.6 percent. The primary US listing showed USD 989.92 on Nasdaq at 3:57 p.m. Eastern on September 22, 2026, down 0.04 percent from the prior close.